GW Pharmaceuticals talk Cannabinoids
London, UK (PRWEB UK) 7 April 2014 -- The industry established Pain Therapeutics conference for combining new pain therapeutic developments with essential networking and collaboration opportunities, will be taking place on 19th and 20th May at the Holiday Inn Kensington Forum, London.
The packed conference agenda will feature a presentation from GW Pharmaceuticals. Their address will be delivered by Director of Research and Development, Dr Stephen Wright. Highlights from the presentation entitled: Cannabinoids in Neuropathic Pain, include:
• What have we learnt?
• Responses to cannabinoids across different neuropathic pain types
• The importance of non-psychoactive cannabinoids
• Cannabinoid modulation of neurotransmission vs inflammation
Dr. Stephen Wright commented: “The role of cannabinoids as a useful therapeutic modality in various chronic pain states has been subject to discussion and investigation over the last decade in particular. The recent success of Sativex, where several cannabinoids are combined with other plant components has cast new light on mechanisms of action and optimal disease targets. The past present and future of cannabinoids as analgesics are discussed in this presentation.”
To see the full speaker line-up and conference agenda click here.
A snapshot of confirmed attendees include:
• Anderson Cancer Center
• Abbott Laboratories
• Eli Lilly
• G W Pharmaceuticals
• Helsinn Healthcare
• Johnson And Johnson
• MC Mutual
• Merck & Co.
• Mundipharma International
• Nektar Therapeutics
• OGB Consulting
• Spinifex Pharmaceuticals
• Stockholm Brain Institute
• Technology & Medicine
• The Medicines Company
• The University Of Sheffield
• UCB
• University of Oxford
• VETOQUINOL
For those who are interested there is currently a £200 Easter Discount available online at http://www.pain-therapeutics.co.uk [DISCOUNT CODE SMI3B9Y].
Pain Therapeutics 2014 will aim to provide attendees with insights on:
• Best Practice – Delegates will be able to share ideas with industry leaders to identify cutting-edge developments including assessing new mechanisms from “Bench to Bedside”, enhancing the translation of animal data into pain patients, key advances in opioids and neuropathic pain.
• Strategy – The conference will include case study driven presentations from leading pharmaceutical and academic KOLS including Merck, UCB, Spinifex, Imperial College London, University of Oxford, AbbVie, Mundipharma, Nektar Pharmaceuticals, Elli Lilly, Janssen plus many more.
• Industry - Topics discussed include assessing alternatives to opioid therapeutics, the translation gap, the discovery of new analgesics, computational approaches for driving drug design cycles, market access and human pharmacology.
• The Future - The conference will analyse the future of pain therapeutics with insights on open innovation, advances to opioids and new tools.
• Join the Debate – Delegates will be invited to participate in a round table discussion led by Nektar Pharmaceuticals, Mundipharma Research and Morpheus on strategies for reduced abuse potential.
• Peer to peer networking - Ample opportunity for discussion, including 2 morning coffee breaks, 2 networking lunches and 2 afternoon tea sessions.
To download the conference brochure and to secure your place Pain Therapeutics 2014, visit http://www.pain-therapeutics.co.uk.
PAIN THERAPEUTICS
19TH 20TH MAY 2014, LONDON UK
Holiday Inn Kensington Forum, London UK
http://www.pain-therapeutics.co.uk
About SMi Group
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.
We pride ourselves on having access to the worlds most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries.
More information can be found at http://www.smi-online.co.uk.
Sonal Patel, SMi Group Ltd, http://www.smi-online.co.uk/2014airmissionplanning14.asp, +44 2078276106, [email protected]
Share this article